The MAP3K8 (Ab-400) antibody is a rabbit polyclonal antibody designed to detect endogenous levels of MAP3K8 protein, specifically targeting the phosphorylation site at serine 400 (Ser400). Its specificity has been validated through affinity purification using epitope-specific immunogens. Validation studies have demonstrated its efficacy in applications such as Western blotting (WB) and immunohistochemistry (IHC), ensuring reliable detection of MAP3K8 protein across various experimental conditions .
Validation data typically include experiments such as Western blot analysis on cell extracts treated with specific stimuli like insulin or environmental stressors. For example, IHC analysis on human ovarian cancer samples confirmed the antibody's ability to selectively bind MAP3K8 protein in clinical specimens . Such validations underpin its reliability for academic research.
Optimizing experimental conditions involves tailoring antibody dilutions, incubation times, and buffer compositions to specific applications. For Western blotting, recommended dilutions range from 1:500 to 1:3000 depending on the target protein concentration and detection sensitivity required . For IHC applications, dilutions between 1:50 and 1:100 are suggested .
Buffer composition plays a critical role in maintaining antibody stability and enhancing binding efficiency. The antibody formulation includes phosphate-buffered saline (PBS) devoid of magnesium and calcium ions, supplemented with sodium azide as a preservative and glycerol for cryoprotection . Researchers should store aliquots at -20°C to prevent freeze-thaw cycles that could degrade antibody activity.
Experimental optimization also requires pilot studies to determine the ideal incubation times and temperatures. For instance, prolonged incubation at lower temperatures can enhance binding specificity during IHC assays. Additionally, blocking steps using bovine serum albumin (BSA) or non-fat milk can minimize non-specific binding.
The MAP3K8 (Ab-400) antibody is primarily used for Western blotting (WB), immunohistochemistry (IHC), and enzyme-linked immunosorbent assay (ELISA). These applications allow researchers to investigate protein expression patterns, post-translational modifications, and signaling pathway dynamics in various biological contexts.
Western blotting with MAP3K8 (Ab-400) enables quantitative analysis of protein expression under different experimental conditions. For example, studies have used this antibody to examine MAP3K8 activation in response to inflammatory stimuli like lipopolysaccharides (LPS) or cytokines such as IL-1 .
IHC applications facilitate spatial localization of MAP3K8 protein within tissue samples. In cancer research, IHC has been employed to correlate MAP3K8 expression with tumor progression and immune infiltration patterns .
ELISA assays using this antibody provide high-throughput quantification of phosphorylated MAP3K8 levels across multiple samples. This application is particularly useful for screening drug candidates targeting the MAPK/ERK pathway .
Phosphorylation at Ser400 is a critical regulatory event that modulates the kinase activity of MAP3K8 within signaling pathways such as the mitogen-activated protein kinase (MAPK) cascade. This post-translational modification enhances the ability of MAP3K8 to activate downstream targets like ERK and JNK kinases .
Functional studies have shown that Ser400 phosphorylation is essential for mediating immune responses through TLR4 signaling in macrophages, leading to TNF-alpha production . Additionally, phosphorylation at this site influences T-helper cell differentiation by regulating IFNG expression . These findings underscore the importance of Ser400 as a functional hotspot within MAP3K8's structure.
Experimental controls are indispensable for ensuring data reliability when investigating MAP3K8 signaling pathways. Key controls include:
Using cell lines or tissue samples devoid of MAP3K8 expression serves as a baseline to assess non-specific binding by the antibody.
Samples treated with known activators of MAP3K8, such as IL-1 or TNF-alpha, provide benchmarks for validating pathway activation.
Rabbit IgG isotype controls help distinguish specific binding from background noise during IHC or ELISA assays .
For Western blotting experiments, loading controls like beta-actin or GAPDH ensure equal protein loading across lanes.
By incorporating these controls into experimental designs, researchers can mitigate artifacts and improve data reproducibility.
Differential expression of MAP3K8 has been implicated in various diseases, including cancers and inflammatory disorders. Elevated levels of MAP3K8 are associated with tumorigenesis through its role in promoting cell proliferation and survival via the ERK pathway .
In renal clear cell carcinoma (ccRCC), high expression levels of MAP3K8 correlate with poor prognosis due to its protumorigenic effects on immune evasion mechanisms . Conversely, reduced expression levels may impair immune responses by limiting cytokine production during bacterial infections . These dual roles highlight the complexity of MAP3K8's involvement in disease pathology.
Bioinformatics tools offer powerful platforms for analyzing gene expression profiles, mutation landscapes, and interactive networks related to MAP3K8:
Platforms like TIMER2.0 and UALCAN enable differential expression analysis across diverse tissue types and disease states .
Tools such as DriverDBv3 and cBioPortal provide insights into mutation frequencies and their functional impacts on signaling pathways involving MAP3K8 .
GeneMANIA and Cytoscape facilitate visualization of protein-protein interaction networks associated with MAP3K8, revealing potential regulatory mechanisms .
By leveraging these tools, researchers can uncover novel insights into the biological roles of MAP3K8.
Contradictory findings often arise due to variations in experimental models, assay conditions, or genetic backgrounds. Addressing these discrepancies requires:
Conducting side-by-side comparisons using standardized protocols can help reconcile differences between datasets.
Independent replication using diverse sample cohorts ensures robustness of observed phenomena.
Focusing on upstream regulators or downstream effectors may clarify conflicting roles attributed to MAP3K8 in immune responses.
For example, while some studies suggest that high levels of MAP3K8 promote tumor immunity by activating NK cells, others report protumorigenic effects through regulatory T cells . Detailed mechanistic studies are essential for resolving such contradictions.
| Application | Dilution Range | Buffer Composition | Storage Conditions |
|---|---|---|---|
| WB | 1:500–1:3000 | PBS + Sodium Azide | -20°C |
| IHC | 1:50–1:100 | PBS + Glycerol | -20°C |
| ELISA | 1:10000 | PBS | -20°C |